www.TheFinancialMarketingGroup.com
Followers | 59 |
Posts | 2,197 |
Boards Moderated | 4 |
Alias Born | 04/28/2019 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
#EVAHF Low-Float Biotech w/ Huge Upside Potentia
EGF Theramed Health Corp. (EVAHF)
Canada: CSE:TMED
Germany: FWB:AUHP
Alert Price: $0.3757
Float: 2.9M
We have been on quite the hot streak as of late.
Our last three winning trade ideas have delivered gains of +97%, +30%, and +105% respectively.
You'll be happy to know that we have just come across another exciting trade idea with monster gain potential.
Please turn your immediate attention to EVAHF (EGF Theramed Health Corp.).
This is one of the most attractive opportunities we've seen in quite some time for several reasons.
The Company:
Is Listed On Major Exchanges In Three Different Countries (U.S., Canada, and Germany)
Trades On The OTCQB, Which Means That It Is Current In Its Reporting, Undergoes Annual Verification & Certification, And Is Not In Bankruptcy
Has A Razor Thin Float
Recently Completed A Big-Time Acquisition
Is Now Operating In A Mental Health Market That Many Experts Believe Is Going To Explode
With its small float, and commitment to growth, EVAHF is cut from the same cloth as our most recent mega-winners.
The Company recently closed a joint venture transaction with Pharmadelic Labs Corp. in which they acquired a 30% interest in the Biosynthesis company.
With this recent acquisition EVAHF is now on the cutting edge when it comes to the treatment of mental health.
EVAHF has begun to research psilocybin and psychedelic extraction and processing which it hopes to use in its Las Vegas extraction lab. Psilocybin microdosing is known to reduce stress, anxiety and pain without many of the side effects associated with traditional pharmacology products that have been prescribed for the same issues.
This comes at a time when a research study suggests that as many as 150,000 additional people could die from mental health-related outcomes.
This could easily be our next trade idea to gain in price, so we suggest you start your research now, and add EVAHF to the top of your watchlist immediately.
About EGF Theramed Health Corp. (OTCQB:EVAHF CSE:MED FWB:AUHP)
EGF Theramed Health Corp. has assets and technologies used in the extraction and purification of botanical extracts and the creation of extract formulations.
Through the Company’s recent acquisition of a 30% equity interest in Pharmadelic Labs Corp. it has begun to research psilocybin and psychedelic biosynthesis and processing for its Las Vegas extraction lab. Psilocybin microdosing has been shown to reduce stress, anxiety and pain without many of the side effects associated with traditional pharmacology products that have been prescribed for the same issues.
About Pharmadelic Labs Corp.
Pharmadelic Labs is genetically designing proprietary processes to help create pharmaceutical grade psilocybin-derived ingredients in a synthetic lab environment. Genetic engineering and biosynthesis expedite a process that creates unique modified psilocybin compounds and precursors in a far more efficient and cost effective manner than traditional methods
Pharmadelic Labs aims to develop a portfolio of intellectual property around biosynthesis pathways for creating compounds. This has great potential for application in many industries including the pharmaceuticals industry.
The company's patent portfolio will develop as follows:
File for provisional patent applications
Continue to update patents as technology develops
Strengthen existing patents with further applications around biosynthesis pathways as results are known
Pharmadelic Labs' biosynthesis process is clean and economical, and much quicker than cultivating mushrooms by themselves – approximately 3 days rather than up to 10 weeks!
It also ensures consistent levels of PSI and is safe due to yeast’s status as Generally Recognized as Safe (GRAS).
The company will also be providing an effective alternative to chemical synthesis. Chemical synthesis of PSI costs upwards of $7K per gram, which is far more expensive than the company's methods.
Very few companies will get an FDA drug approved, maybe a handful at best, hundreds of them will attempt to do so as the race has ultimately begun for PSY billions as the sector opens up, but everyone will need an edge over their competition.
This edge is not in the drug itself or the molecule, or the compound, but may be in the process and the way the compound is mass produced in a lab environment.
Here Is How The Biosynthesis Of PSI Works:
Step 1 Order synthetic DNA from hal*luc*ino*genic mushrooms
Step 2 Install DNA into genome of industrial brewing yeast
Step 3 Cultivate yeast on a large scale
Step 4 Extract PSI
Step 5 Create pharmaceutical product
PSI May Be The Next Breakthrough Therapy For Depression and Other Mental Issues
Ma*gic mushrooms are the safest “recreational” drug to take and those who take them are the most sensible and well prepared, according to the 2017 Global Drug Survey. Out of almost 10,000 people who took them, only 0.2% needed emergency medical treatment.
Ongoing clinical trials are discovering the uses of PSI in the treatment of addiction and other mental health problems.
The "Green Wave" rush when it emerged sent MJ related stocks soaring as the plant promises to offer a long list of benefits for various ailments.
More and more studies are examining the properties of PSI, and the enormous effects that it can have on the huge global problem of treating mental health.Check out some of the studies around PSI:
A single dose of the PSY ingredient in "ma*gic mushrooms" may bring long-lasting relief to cancer patients who suffer anxiety and depression, a new, small study suggests. (SOURCE)
Doctors Are Turning to PSYs to Treat Depression and Addiction (SOURCE)
A Radical Approach to Beating Addiction (SOURCE)
Doctors Are Giving Alzheimer's Patients L-S-D (SOURCE)
Researchers from the University of South Florida discover that PSI can also bind itself to receptors that stimulate healing. (SOURCE)
Mental Health Market Creates Tremendous Revenue Potential
According to the Centers for Disease Control, suicide was the 10th leading cause of death in the US in 2017.
Healthypeople. gov has found that in any given year, over 18% of US adults suffer from mental illness.
Forbes has reported that mental illness costs the U.S. economy nearly $200B a year.
According to Brands Essence Research, the global antidepressant drugs market was estimated to be over $13.5Bn in 2018 and is predicted to rise to nearly $16B by 2025.
36% of Americans told an American Psychiatric Association poll that the pandemic has had a serious impact on their mental health, and according to a PiplSay poll, 31% of Americans say they’re sleeping less because of c-virus-related anxiety.
As people self-quarantine, remote therapy services like Talkspace and Brightside have seen an increase in demand. In fact, Talkspace told Bloomberg at the beginning of April that it experienced a 65% increase in customers since mid February and Brightside has seen a 50% increase in new users since the start of the year.
EVAHF Is Positioning Itself To Help Solve A $280 Billion Per Year Problem In The U.S.
Mental health is one of the biggest unsolved health problems in the world. It is pervasive; it is estimated that up to one quarter of Americans can suffer a mental disorder in any given year. This has a striking economic impact ; treating mental health is estimated to cost the US more than $280 billion per year - before economic losses due to time off work is calculated. The global antidepressants market is estimated to grow to over $22 billion by 2025 - this represents a huge potential market for psychedelic drugs to enter.
Current treatments such as opioids have potentially harmful side effects such as addictiveness, but psychedelic drugs like psilocybin may avoid these downsides of addiction. An article published by Johns Hopkins University in 2018 recommended that the government downgrade psilocybin's classification to Schedule IV: a drug with "low potential for abuse and low risk of dependence". It has shown promising results in treating depression, as well as in palliative care.
As the government and more pharmaceutical companies recognize the medical treatment potential of psychedelic substances, it is important that access to compounds like psilocybin is made easier. Pharmadelic Labs is aiming to achieve this by creating biosynthesis pathways for psilocybin.
FDA Calls Psychedelic Psilocybin a 'Breakthrough Therapy' for Forms of Depression
The FDA is helping to speed up the process of researching and approving psilocybin, a hallucinogenic substance in magic mushrooms, to treat major depressive disorder ( MDD ).
For the second time in a year, the U.S. Food and Drug Administration (FDA) has designated psilocybin therapy — currently being tested in clinical trials — as "breakthrough therapy," an action that is meant to accelerate the typically sluggish process of drug development and review. It is typically requested by a drug company and granted only when preliminary evidence suggests the drug may be an enormous improvement over already available therapy, according to the FDA.
Last year, the FDA granted "breakthrough therapy" status to psilocybin therapy in the still-ongoing clinical trials run by the company Compass Pathways, which are looking into psilocybin's potential to treat severe treatment-resistant depression, or depression in patients who have not improved after undergoing two different antidepressant treatments, according to New Atlas.
Recent News
EGF Theramed Health Announces Leased Facilities for Pharmadelic Labs
Two weeks ago, the Company announced that its joint venture partner, Pharmadelic Labs Corp. ("Pharmadelic Labs"), in which the Company holds a 30% equity interest, has secured additional lab facility space in order to expand its research and development of proprietary processes to help create pharmaceutical grade psilocybin-derived ingredients in a synthetic lab environment.
Pharmadelic Labs has a leased space at a lab facility in Burnaby, British Columbia at a cost of $3,000 per month expiring May 1, 2021 and has begun plans for some minor retrofitting in advance of ordering/receiving DNA and certain lab equipment. Operations in Burnaby will focus on research on precursor molecules such as 4-hydroxytryptamine, norbaeocystin, baeocystin, and norpsilocin, which are not on the controlled substances list in Canada. There are also derivatives of 4-hydroxytryptamine and norpsilocin that will be pursued during this phase of research and development.
The ongoing research will focus on the genetic engineering of yeast for biosynthesis of these target molecules. Testing will be conducted using HPLC with mass spec ( LC / MS ) for metabolite analysis, while DNA sequencing will be used for confirmation of genetic modifications and genomic installations. Once small-scale fermentations are ready for trial there will be investigations into optimizing the metabolic pathway(s) of interest.
Pharmadelic Labs has also entered into a lease for a lab facility in Victoria, British Columbia at a cost of $5,000 per month effective August 1, 2020. The lease has an initial term of six months and is renewable at the Company's option and the satisfaction of certain conditions. The parties are currently working together reviewing lab equipment requirements in order to acquire the necessary equipment for this location. Once the lab is set-up, it is expected that Pharmadelic Labs will move all Canadian operations to Victoria and it will become their headquarters for ongoing research and development activities with precursor molecules, as well as controlled-substances, subject to drug research exemptions from the appropriate regulatory institutions.
Under the joint venture agreement, the Company has advanced funds to Pharmadelic Labs to allow it to move forward with patent filings focusing on biosynthesis of derivatives of tryptamine/psilocybin and several precursors there-in. Pharmadelic Labs is continuing to examine different DNA samples from various psilocybin producing mushrooms to determine the optimal one to use in the biosynthesis process with yeast.
Market Outlook
Studies Have Shown a Possible Increase In Drug Deaths as High as 150K
There is a research model going around that suggests as many as 150,000 additional people could die from mental health-related outcomes.
The federal mental health czar is calling for more money to expand services to help people suffering amid the social isolation, as a new study estimates related deaths from alcohol, drug overdose and suicide could reach 150,000.
"We see very troubling signs across the nation," said Dr . Elinore McCance-Katz, assistant secretary at Department of Health and Human Services and head of the Substance Abuse and Mental Health Administration. "There's more substance abuse, more overdoses, more domestic violence and neglect and abuse of children."
McCance-Katz said the agency wants more money for services to address an anticipated surge in need for mental health and addiction treatment, which was already in short supply. She cited HHS' own substance abuse and mental health research and a February report in the British journal The Lancet on the psychological effects of quarantine
The Lancet study said the effects can include post-traumatic stress disorder and suicide and are "wide-ranging, substantial, and can be long lasting." That's especially true if there isn't a clear end in sight, like now, said McCance-Katz.
The new study, released Friday by the Well Being Trust and the American Academy of Family Physicians, factored in isolation and uncertainty when it calculated the expected deaths from suicide, alcohol and drugs, based on nine unemployment scenarios.
The likely toll from these "deaths of despair" was the loss of an additional 75,000 lives, the study found. Death estimates ranged from 27,644 if the economy recovers quickly, to 154,037 if recovery is slow.
Based on the data we've read, it appears that a sharp increase in spending toward mental health is inevitable.
This is certainly not the most uplifting news, but we do see it as a bullish catalyst for EVAHF.
Technical Analysis
EVAHF Has A Razor Thin Float And Tremendous Upside Potential
Potential Bullish Reversal In The Making
We did our very own technical analysis , and see the potential for a major move from here.
Bullish Indicators
Beautiful Bottom And Reversal Formed
Bullish Reversal
Momentum Back Above Zero-Line
As we've seen with our past winners, these low-float alerts have the tendency to bounce back hard, and can go viral at any moment.
The Company is trading well below its 52-week high of $4.00 giving it almost unlimited upside potential from today's alert price.
The Bottom Line
With its low-float, EVAHF is a day traders dream come true.
The Company appears to be in the midst of a major growth stage, and could rally hard from today's alert price.
We love their recent strategic acquisition, and believe it will serve as a major source of revenue in the very near future.
As we mentioned above, this could easily be our next trade idea to double in price, so we suggest you start your research now, and add it to the top of your watchlist immediately.By Viewing this Content, you Agree that you Have Read and are in Full Understanding of both our Disclaimer & Privacy Policy(*Remember to use a Stop-Loss Order to protect your gains, as well as limit possible losses.)
Best regards,
$BRGO | #Bergio - Low Float Bounce Play w/ Huge Upside
Bergio International, Inc. (BRGO)
Alert Price: $0.04
Float: 8.56M
Technical Analysis
We ended last week with a two-day +30% winner.
Our trade alert prior to that more than doubled in price in just a few days.
You'll be happy to know that we have just discovered another exciting trade idea with triple-digit gain potential.
Please turn your immediate attention to Bergio International, Inc. (BRGO).
Bergio, is one of the most coveted brands of fine jewelry. Established in 1995, Bergio’s signature innovative design, coupled with extraordinary diamonds and precious stones, earned the company recognition as a highly sought-after purveyor of rare and exquisite treasures from around the globe.
When designer and CEO , Berge Abajian, creates a collection, he looks well beyond the drawing board. Berge focuses on the woman who will ultimately wear his pieces, bringing to creation a magnificent piece of jewelry that reflects the beauty and vitality a woman possesses. Bergio creations are a seamless blend of classic elegance and subtle flair, adding to a woman’s charm while never overpowering her.
BRGO appears to be extremely oversold/undervalued at the moment.
On Friday BRGO witnessed a huge selloff, setting up one of the most attractive bounce opportunities that we have seen in quite some time.
Shares of BRGO seemed to have found their bottom, and with its razor thin float of just 8.56M, we could see huge move from this highly volatile ticker.
The Bullish Case For BRGO
Chart is trending bullish
Is operating in a sector that is set for growth
Has a razor thin float
Has tremendous upside potential
Sitting on a bottom'd out chart
We have a feeling that BRGO could be our next trade idea to more than double in price.
That being said, we ask that you add it to the top of your watchlist immediately, and be ready to trade at 9:30AM EST.
About Bergio International, Inc.
The Bergio brand is our most important asset. The Bergio brand is associated with high-quality, handcrafted and individually designed pieces with European sensibility, Italian craftsmanship and a bold flair for the unexpected. Bergio, is one of the most coveted brands of fine jewelry. Established in 1995, Bergio's signature innovative design, coupled with extraordinary diamonds and precious stones, earned the company recognition as a highly sought-after purveyor of rare and exquisite treasures from around the globe. As President, CEO and Head Designer of Bergio, Berge Abajian performs a highly successful balancing act, accomplished with equal parts precision and passion. An informed and inspirational leader, Berge directs the company with the eye and soul of a designer and the mind of a businessman. The role that is perhaps closest to his heart, however, is that of designer. With family jewelry roots reaching back the 1930s, Berge is a third generation jeweler and a purist when it comes to design. Berge's understanding of every aspect, in both design and manufacturing, creates collections that are nothing short of peerless in craftsmanship and style. Berge creates a collection, he looks well beyond the drawing board. Berge focuses on the woman who will ultimately wear his pieces, bringing to creation a magnificent piece of jewelry that reflects the beauty and vitality a woman possesses. Bergio creations are a seamless blend of classic elegance and subtle flair, adding to a woman's charm while never overpowering her.
It is our intention to establish Bergio as a holding company for the purpose of establishing retails stores worldwide. Our branded product lines are products and/or collections designed by our designer and CEO Berge Abajian and will be the centerpiece of our retail stores. We also intend to complement our own quality-designed jewelry with other products and our own specially-designed handbags. This is in line with our strategy and belief that a brand name can create an association with innovation, design and quality which helps add value to the individual products as well as facilitate the introduction of new products.
For further information please visit our website at www.bergio.com.
BRGO Could See A Substantial Increase In Revenue
Bergio International Implementing A New Direction
Last month the Company reported that it is implementing a new direction to improve revenues. Bergio will be launching its own live channel direct to consumer to be broadcasted live 3 times a week from its store location in the Ocean Casino Resort in Atlantic City NJ. The launch date will be predicated on opening of the casino. We anticipate being up and live within 30 days unless there are additional delays from the State.
Berge Abajian, CEO of Bergio stated "the introduction of our online live broadcast is a great addition to our existing business. We have succeeded in transforming our business the past 5 years from strictly wholesale to selling direct to consumer. This platform provides us the opportunity to penetrate the worldwide market. My vision and direction, which was painful to execute, has moved us in the right direction. Our gross margins have increased tremendously and are operating expenses are under control, providing for a highly leveraged company. We believe that revenues will increase as a result of this new strategy and provide improved profitability in the future. While jewelry market has experienced a modest downturn which has caused a decline in our revenues, this new platform should allow and provide more worldwide market penetration. Bergio is ready for the future as we have worked hard on our product mix and added accessories & Silver Fashion Jewelry in 2019 with a great price point that gives our consumer base a large selection to pick from."
CEO Paints Positive Outlook For The Future
The Company continues to position itself for the future to take advantage of the Bergio brand and establish a chain of retail stores worldwide.
Mr. Berge Abajian, President & CEO stated "this was a difficult quarter and our business has been impacted by the pandemic. However, we are expanding our online presence and have been experiencing some positive results, which we believe will be reflected in the second quarter results, but it is too early to assess the real impact . The Company continues to position itself for the future to take advantage of the Bergio brand and establish a chain of retail stores worldwide. Our branded product lines are products and/or collections designed by our designer and CEO Berge Abajian and will be the centerpiece of our retail stores. We also intend to complement our own quality-designed jewelry with other products and our own specially-designed handbags. This is in line with our strategy and belief that a brand name can create an association with innovation, design and quality which helps add value to the individual products as well as facilitate the introduction of new products with higher profit margins."
"While the impact of the pandemic still provides some uncertainty, we continue to be excited about our future. The Company has leveraged itself such that as sales increase a larger portion of dollars will flow to the bottom line."
"The Company continues to pursue additional financing opportunities. Financing discussions have been taking place with various parties, but the Company has no firm commitment from any party to provide additional funding at this time."
He added, "I appreciate all the support from our shareholders and wishing all to stay safe through these unprecedented times, with a bright future is ahead".
We could be at the start of a major turnaround for BRGO.
Those who start building a position in BRGO now could be handsomely rewarded in the very near future.
Market Outlook
The value of the jewelry market is expected to increase from about 279 billion U.S. dollars in 2018 to about 480.5 billion dollars by 2025.
The Global Online Jewelry Market is expected to grow by $ 19.88 bn during 2020-2024 progressing at a CAGR of 15% during the forecast period
Technical Analysis
BRGO Could See A Major Reversal
We've done our very own technical analysis , and see the potential for an over +200% move from here.
Bullish Indicators:
RSI On Uptrend Support
Market Weakness Brought Panic Selling, Stock Now Sitting On Long-Term Support, Offering Huge Upside Reversal Potential
Histogram In Bullish Divergence To Price
BRGO is no stranger to big time single-session moves.
One just has to examine its price history, to see that this ticker can run like the wind.
On 6/25 shares ran up over +96% from $0.0402 to $0.0789.
On 6/23 shares ran up over +272% from $0.0403 to $0.15.
On 5/19 shares ran up over +308% from $0.0333 to $0.136.
On 5/14 shares ran up over +249% from $0.04 to $0.1399.
As you can see, BRGO can move fast and move big!
Those looking for a trade with monster gain potential need not look any further than BRGO.
The Bottom Line
This could be the biggest bounce opportunity of the summer.
BRGO has a razor thin float, and a proven history of big moves.
The Company appears committed to a turnaround, and we have a bullish outlook for BRGO.
As we mentioned above, this could easily be our next trade idea to double in price, so we suggest you start your research now, and add it to the top of your watchlist immediately.By Viewing this Content, you Agree that you Have Read and are in Full Understanding of both our Disclaimer & Privacy Policy(*Remember to use a Stop-Loss Order to protect your gains, as well as limit possible losses.) Best regards
$BRGO | #Bergio - Low Float Bounce Play w/ Huge Upside
Bergio International, Inc. (BRGO)
Alert Price: $0.04
Float: 8.56M
Technical Analysis
We ended last week with a two-day +30% winner.
Our trade alert prior to that more than doubled in price in just a few days.
You'll be happy to know that we have just discovered another exciting trade idea with triple-digit gain potential.
Please turn your immediate attention to Bergio International, Inc. (BRGO).
Bergio, is one of the most coveted brands of fine jewelry. Established in 1995, Bergio’s signature innovative design, coupled with extraordinary diamonds and precious stones, earned the company recognition as a highly sought-after purveyor of rare and exquisite treasures from around the globe.
When designer and CEO , Berge Abajian, creates a collection, he looks well beyond the drawing board. Berge focuses on the woman who will ultimately wear his pieces, bringing to creation a magnificent piece of jewelry that reflects the beauty and vitality a woman possesses. Bergio creations are a seamless blend of classic elegance and subtle flair, adding to a woman’s charm while never overpowering her.
BRGO appears to be extremely oversold/undervalued at the moment.
On Friday BRGO witnessed a huge selloff, setting up one of the most attractive bounce opportunities that we have seen in quite some time.
Shares of BRGO seemed to have found their bottom, and with its razor thin float of just 8.56M, we could see huge move from this highly volatile ticker.
The Bullish Case For BRGO
Chart is trending bullish
Is operating in a sector that is set for growth
Has a razor thin float
Has tremendous upside potential
Sitting on a bottom'd out chart
We have a feeling that BRGO could be our next trade idea to more than double in price.
That being said, we ask that you add it to the top of your watchlist immediately, and be ready to trade at 9:30AM EST.
About Bergio International, Inc.
The Bergio brand is our most important asset. The Bergio brand is associated with high-quality, handcrafted and individually designed pieces with European sensibility, Italian craftsmanship and a bold flair for the unexpected. Bergio, is one of the most coveted brands of fine jewelry. Established in 1995, Bergio's signature innovative design, coupled with extraordinary diamonds and precious stones, earned the company recognition as a highly sought-after purveyor of rare and exquisite treasures from around the globe. As President, CEO and Head Designer of Bergio, Berge Abajian performs a highly successful balancing act, accomplished with equal parts precision and passion. An informed and inspirational leader, Berge directs the company with the eye and soul of a designer and the mind of a businessman. The role that is perhaps closest to his heart, however, is that of designer. With family jewelry roots reaching back the 1930s, Berge is a third generation jeweler and a purist when it comes to design. Berge's understanding of every aspect, in both design and manufacturing, creates collections that are nothing short of peerless in craftsmanship and style. Berge creates a collection, he looks well beyond the drawing board. Berge focuses on the woman who will ultimately wear his pieces, bringing to creation a magnificent piece of jewelry that reflects the beauty and vitality a woman possesses. Bergio creations are a seamless blend of classic elegance and subtle flair, adding to a woman's charm while never overpowering her.
It is our intention to establish Bergio as a holding company for the purpose of establishing retails stores worldwide. Our branded product lines are products and/or collections designed by our designer and CEO Berge Abajian and will be the centerpiece of our retail stores. We also intend to complement our own quality-designed jewelry with other products and our own specially-designed handbags. This is in line with our strategy and belief that a brand name can create an association with innovation, design and quality which helps add value to the individual products as well as facilitate the introduction of new products.
For further information please visit our website at www.bergio.com.
BRGO Could See A Substantial Increase In Revenue
Bergio International Implementing A New Direction
Last month the Company reported that it is implementing a new direction to improve revenues. Bergio will be launching its own live channel direct to consumer to be broadcasted live 3 times a week from its store location in the Ocean Casino Resort in Atlantic City NJ. The launch date will be predicated on opening of the casino. We anticipate being up and live within 30 days unless there are additional delays from the State.
Berge Abajian, CEO of Bergio stated "the introduction of our online live broadcast is a great addition to our existing business. We have succeeded in transforming our business the past 5 years from strictly wholesale to selling direct to consumer. This platform provides us the opportunity to penetrate the worldwide market. My vision and direction, which was painful to execute, has moved us in the right direction. Our gross margins have increased tremendously and are operating expenses are under control, providing for a highly leveraged company. We believe that revenues will increase as a result of this new strategy and provide improved profitability in the future. While jewelry market has experienced a modest downturn which has caused a decline in our revenues, this new platform should allow and provide more worldwide market penetration. Bergio is ready for the future as we have worked hard on our product mix and added accessories & Silver Fashion Jewelry in 2019 with a great price point that gives our consumer base a large selection to pick from."
CEO Paints Positive Outlook For The Future
The Company continues to position itself for the future to take advantage of the Bergio brand and establish a chain of retail stores worldwide.
Mr. Berge Abajian, President & CEO stated "this was a difficult quarter and our business has been impacted by the pandemic. However, we are expanding our online presence and have been experiencing some positive results, which we believe will be reflected in the second quarter results, but it is too early to assess the real impact . The Company continues to position itself for the future to take advantage of the Bergio brand and establish a chain of retail stores worldwide. Our branded product lines are products and/or collections designed by our designer and CEO Berge Abajian and will be the centerpiece of our retail stores. We also intend to complement our own quality-designed jewelry with other products and our own specially-designed handbags. This is in line with our strategy and belief that a brand name can create an association with innovation, design and quality which helps add value to the individual products as well as facilitate the introduction of new products with higher profit margins."
"While the impact of the pandemic still provides some uncertainty, we continue to be excited about our future. The Company has leveraged itself such that as sales increase a larger portion of dollars will flow to the bottom line."
"The Company continues to pursue additional financing opportunities. Financing discussions have been taking place with various parties, but the Company has no firm commitment from any party to provide additional funding at this time."
He added, "I appreciate all the support from our shareholders and wishing all to stay safe through these unprecedented times, with a bright future is ahead".
We could be at the start of a major turnaround for BRGO.
Those who start building a position in BRGO now could be handsomely rewarded in the very near future.
Market Outlook
The value of the jewelry market is expected to increase from about 279 billion U.S. dollars in 2018 to about 480.5 billion dollars by 2025.
The Global Online Jewelry Market is expected to grow by $ 19.88 bn during 2020-2024 progressing at a CAGR of 15% during the forecast period
Technical Analysis
BRGO Could See A Major Reversal
We've done our very own technical analysis , and see the potential for an over +200% move from here.
Bullish Indicators:
RSI On Uptrend Support
Market Weakness Brought Panic Selling, Stock Now Sitting On Long-Term Support, Offering Huge Upside Reversal Potential
Histogram In Bullish Divergence To Price
BRGO is no stranger to big time single-session moves.
One just has to examine its price history, to see that this ticker can run like the wind.
On 6/25 shares ran up over +96% from $0.0402 to $0.0789.
On 6/23 shares ran up over +272% from $0.0403 to $0.15.
On 5/19 shares ran up over +308% from $0.0333 to $0.136.
On 5/14 shares ran up over +249% from $0.04 to $0.1399.
As you can see, BRGO can move fast and move big!
Those looking for a trade with monster gain potential need not look any further than BRGO.
The Bottom Line
This could be the biggest bounce opportunity of the summer.
BRGO has a razor thin float, and a proven history of big moves.
The Company appears committed to a turnaround, and we have a bullish outlook for BRGO.
As we mentioned above, this could easily be our next trade idea to double in price, so we suggest you start your research now, and add it to the top of your watchlist immediately.By Viewing this Content, you Agree that you Have Read and are in Full Understanding of both our Disclaimer & Privacy Policy(*Remember to use a Stop-Loss Order to protect your gains, as well as limit possible losses.) Best regards
$NVDA | Must Help Lead any Recovery
Although selling was quite heavy on Friday, damage was limited to 5% from the recent highs.
Much depends on NVDA remaining strong and some help from AMD could help stabilize the SMH
$364 is Hourly support.
$361 & $352 are Daily Supports
Middle Bollinger Band could be tested and bulls will try to hold once again.
Local Fibonacci Support sits at $362 level.
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
$NVDA | Must Help Lead any Recovery
Although selling was quite heavy on Friday, damage was limited to 5% from the recent highs.
Much depends on NVDA remaining strong and some help from AMD could help stabilize the SMH
$364 is Hourly support.
$361 & $352 are Daily Supports
Middle Bollinger Band could be tested and bulls will try to hold once again.
Local Fibonacci Support sits at $362 level.
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
$BA | Big Week Ahead for #Boeing
Levels to watch next week if we get a recovery due to positive 747 testing.
$170 is historical support & major pivot point
$173.43 is the Major Fibonacci .236 retracement level.
$187 Is a major pivot point that Bulls need to reclaim.
Next major support zone is at the $160-$155 level
where Fibs and the 50ma converge.
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
$BA | Big Week Ahead for #Boeing
Levels to watch next week if we get a recovery due to positive 747 testing.
$170 is historical support & major pivot point
$173.43 is the Major Fibonacci .236 retracement level.
$187 Is a major pivot point that Bulls need to reclaim.
Next major support zone is at the $160-$155 level
where Fibs and the 50ma converge.
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
$NKLA | #Nikola Chart Review
Broken bearishly from wedge on Friday.
Currently sitting on critical support-
-Volume Shelf
-Daily horizontal support
Support below this level is very limited and it
must also be remembered that the current valuation is very Similar to Ford,
#while having ZERO sales.
Indicators are bearish and rolling over.
Speculative stock and high risk at current valuation.
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
$NKLA | #Nikola Chart Review
Broken bearishly from wedge on Friday.
Currently sitting on critical support-
-Volume Shelf
-Daily horizontal support
Support below this level is very limited and it
must also be remembered that the current valuation is very Similar to Ford,
#while having ZERO sales.
Indicators are bearish and rolling over.
Speculative stock and high risk at current valuation.
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
$GOOGL | #Alphabet A Political Pawn $GOOG
Alphabet Inc has a tough few weeks ahead, as mainstream media
have grabbed the current turmoil in the world to try and grasp control of
advertising spend once again.
The political and social situation is toxic in the USA and
TWTR FB & GOOGL are now weapons in a political game as the election approaches.
Downside may continue but temporary once major companies realize the need these
platforms more than token gestures of support.
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
$GOOGL | #Alphabet A Political Pawn $GOOG
Alphabet Inc has a tough few weeks ahead, as mainstream media
have grabbed the current turmoil in the world to try and grasp control of
advertising spend once again.
The political and social situation is toxic in the USA and
TWTR FB & GOOGL are now weapons in a political game as the election approaches.
Downside may continue but temporary once major companies realize the need these
platforms more than token gestures of support.
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
$MSFT | #Microsoft will FANG drag it Down?
MSFT lost the $200 level as support
$194 and $186 are first levels of horizontal support
while the 12ma held as support on Friday.
20ma sits in confluence a gap @ $190 that could get filled.
Breaking the trend-line will give the Bears a point of weakness to attack.
It is also possible that the weakness in FB & GOOGL will bring weakness tot he door of the
other FANG stocks.
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
$MSFT | #Microsoft will FANG drag it Down?
MSFT lost the $200 level as support
$194 and $186 are first levels of horizontal support
while the 12ma held as support on Friday.
20ma sits in confluence a gap @ $190 that could get filled.
Breaking the trend-line will give the Bears a point of weakness to attack.
It is also possible that the weakness in FB & GOOGL will bring weakness tot he door of the
other FANG stocks.
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
$AAPL | #Apple Strong Amid The Weakness
Trendline still intact.
12ma has been support since early April.
Horizontal support at $351
Horizontal resistance at $365
RSI is no longer overbought.
AAPL will be the stock to watch next week for
first signs of strength.
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
$AAPL Apple Strong Amid The Weakness
Trendline still intact.
12ma has been support since early April.
Horizontal support at $351
Horizontal resistance at $365
RSI is no longer overbought.
AAPL will be the stock to watch next week for
first signs of strength.
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
$CAKE | #CheesecakeFactory Potential Reversal
Possible reversal setting up in CAKE next week.
Heavy selling last week found support on the
Fibonacci Golden Pocket and the Point of Control (redline)
If thsi levels fails to hold on Monday the rising
Fibonacci channel will be the next level to watch.
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
$CAKE | #CheesecakeFactory Potential Reversal
Possible reversal setting up in CAKE next week.
Heavy selling last week found support on the
Fibonacci Golden Pocket and the Point of Control (redline)
If thsi levels fails to hold on Monday the rising
Fibonacci channel will be the next level to watch.
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
$SONO | #Sonos Inc Upside Targets
Upside targets -
$16.00 to historical horizontal resistance
$17.00 to Fibonacci Golden Pocket
Possible entry on break above .5 Fib level and the
Point of Control ( POC )
Speculation has ignited a rally that looks sustainable.
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
$SONO | #Sonos Inc Upside Targets
Upside targets -
$16.00 to historical horizontal resistance
$17.00 to Fibonacci Golden Pocket
Possible entry on break above .5 Fib level and the
Point of Control ( POC )
Speculation has ignited a rally that looks sustainable.
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
$SFM | #SproutsFarmersMarkets Bull-Flag
Possible BullFlag breakout imminent
Strong horizontal resistance at $24.40
Targets as per resistance levels with $28.00
as a medium term target.
MACD Bullish Reversal
Histogram crossing Zero-line
RSI uptrending with room to run higher.
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
$SFM | #SproutsFarmersMarkets Bull-Flag
Possible BullFlag breakout imminent
Strong horizontal resistance at $24.40
Targets as per resistance levels with $28.00
as a medium term target.
MACD Bullish Reversal
Histogram crossing Zero-line
RSI uptrending with room to run higher.
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
$ZYNE Possible breakout for #Zynerba
Possible entry above $6.70
Upside target $7.86 - $8.50
Very high short interest at 30%
Company Profile
Zynerba Pharmaceuticals , Inc. engages in the provision of pharmaceutically-produced transdermal cannabinoid therapies. It focuses on research and development of rare and near-rare neuropsychiatric conditions. It offers Zygel product which formulated as a permeation-enhanced gel for transdermal delivery. The company was founded by Audra L. Stinchcomb on January 31, 2007 and is headquartered in Devon, PA.
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
$ZYNE Possible breakout for #Zynerba
Possible entry above $6.70
Upside target $7.86 - $8.50
Very high short interest at 30%
Company Profile
Zynerba Pharmaceuticals , Inc. engages in the provision of pharmaceutically-produced transdermal cannabinoid therapies. It focuses on research and development of rare and near-rare neuropsychiatric conditions. It offers Zygel product which formulated as a permeation-enhanced gel for transdermal delivery. The company was founded by Audra L. Stinchcomb on January 31, 2007 and is headquartered in Devon, PA.
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
$SNAP All Time High on the Horizon
Facebook's loss is SNAP's gain,
Not alone will it benefit from diverted advertisement spend from Fb ,
but we must also consider the fact that investors are also changing sides.
Our Huge Inverse H&S target is still in play, but short
term lets aim for the ATH of $29.38
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
$SNAP All Time High on the Horizon
Facebook's loss is SNAP's gain,
Not alone will it benefit from diverted advertisement spend from Fb ,
but we must also consider the fact that investors are also changing sides.
Our Huge Inverse H&S target is still in play, but short
term lets aim for the ATH of $29.38
PLEASE GIVE US A LIKE IF YOU FIND OUR CONTENT HELPFUL, THANK YOU.
$SHIP Risky Into Earnings
Seanergy Maritime Holdings Corp. operates as an international shipping company specializing in the worldwide seaborne transportation of dry bulk commodities . It focuses on owning and management of fleet of Capesize bulk carriers. The company was founded on January 4, 2008 and is headquartered in Athens, Greece.
$SHIP Risky Into Earnings
Seanergy Maritime Holdings Corp. operates as an international shipping company specializing in the worldwide seaborne transportation of dry bulk commodities . It focuses on owning and management of fleet of Capesize bulk carriers. The company was founded on January 4, 2008 and is headquartered in Athens, Greece.
$IMUX | #Immunic Inc On Breakout Watch | #TopMarketGainers
Major breakout potential
Golden cross complete
Company Profile
Immunic , Inc. develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. Its products include IMU-838, IMU-935, and IMU-856. The company is headquartered in San Diego, CA.
$IMUX | #Immunic Inc On Breakout Watch | #TopMarketGainers
Major breakout potential
Golden cross complete
Company Profile
Immunic , Inc. develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. Its products include IMU-838, IMU-935, and IMU-856. The company is headquartered in San Diego, CA.
$ZYNE | #Zynerba Trade Setup
Very high short interest at 30%
Stock is currently well below the average analyst price target of $18 and a BUY rating.
Company profile
Zynerba Pharmaceuticals , Inc. engages in the provision of pharmaceutically-produced transdermal cannabinoid therapies. It focuses on research and development of rare and near-rare neuropsychiatric conditions. It offers Zygel product which formulated as a permeation-enhanced gel for transdermal delivery. The company was founded by Audra L. Stinchcomb on January 31, 2007 and is headquartered in Devon, PA.
$ZYNE | #Zynerba Trade Setup
Very high short interest at 30%
Stock is currently well below the average analyst price target of $18 and a BUY rating.
Company profile
Zynerba Pharmaceuticals , Inc. engages in the provision of pharmaceutically-produced transdermal cannabinoid therapies. It focuses on research and development of rare and near-rare neuropsychiatric conditions. It offers Zygel product which formulated as a permeation-enhanced gel for transdermal delivery. The company was founded by Audra L. Stinchcomb on January 31, 2007 and is headquartered in Devon, PA.